Killer cell immunoglobulin-like receptor genes in patients with breast cancer

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 511-515

  Ozturk, Ozlem Goruroglu ^a   Gun, Faik Deniz ^b   Polat, Gurbuz ^c  

^a CUKUROVA UNIVERSITY   (Turkey)

^b Birecik State Hospital   (Turkey)

^c MERSIN UNIVERSITY   (Turkey)

Author keywords

Breast cancer; HLA class I; KIR genes; KIRs; Luminex

Indexed keywords

KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL3; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DP1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DS4; UNCLASSIFIED DRUG; KIR2DS1 PROTEIN, HUMAN; KIR3DL3 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; AGED; BREAST TUMOR; CANCER STAGING; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; HAPLOTYPE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTORS, KIR; RECEPTORS, KIR2DL4; RECEPTORS, KIR3DL2;

EID: 84866290229     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9932-x     Document Type: Article

References (29)

1. Khong HT, Restifo NP. Natural selection of tumor variants in the generation of "tumor escape" phenotypes. Nat Immunol. 2002;3: 999-1005.
2. Caligiuri MA. Human natural killer cells. Blood. 2008;112: 461-9.
3. Ljunggren HG, Karre K. In search of the 'missing self'. MHC molecules and NK cell recognition. Immunol Today. 1990;11: 237-44.
4. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol. 2002;20: 217-51.
5. Middleton D, Williams F, Halfpenny IA. KIR genes. Transpl Immunol. 2005;14:135-42.
6. Bao X, et al. An allelic typing method for 2DS4 variant used in study of haplotypes of killer cell immunoglobulin-like receptor gene. Int J Lab Hematol. 2010;32:625-32.
7. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15 year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
8. Madigan MP, Ziegler RG, Benichou J, Byrne C, Hoover RN. Proportion of breast cancer cases in the United States explained by well-established risk factors. J Natl Cancer Inst. 1995;87: 1681-5.
9. Nagasaki K, Miki Y. Gene expression profiling of breast cancer. Breast Cancer. 2006;13:2-7.
10. Turnbull C, Hodgson S. Genetic predisposition to cancer. Clin Med. 2005;5:491-8.
11. Algarra I, Garcia-Lora A, Cabrera T, Ruiz-Cabello F, Garrido F. The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape. Cancer Immunol Immunother. 2004;53: 904-10.
12. Cabrera T, et al. High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Hum Immunol. 1996;50: 127-34.
13. Khakoo SI, Carrington M. KIR and disease: a model system or system of models? Immunol Rev. 2006;214:186-201.
14. Carlsten M, Malmberg KJ, Ljunggren HG. Natural killer cellmediated lysis of freshly isolated human tumor cells. Int J Cancer. 2009;124:757-62.
15. Boyton RJ, Altmann DM. Natural killer cells, killer immunoglobulin-like receptors and human leucocyte antigen class I in disease. Clin Exp Immunol. 2007;149:1-8.
16. Möller P, Hammerling GJ. The role of surface HLA-A, B, C molecules in tumour immunity. Cancer Surv. 1992;13:101-27.
17. Yawata M, et al. MHC class I-specific inhibitory receptors and their ligands structure diverse human NK cell repertoires toward a balance of missing self-response. Blood. 2008;112:2369-80.
18. Jonsson AH, Yokoyama WM. Natural killer cell tolerance licensing and other mechanisms. Adv Immunol. 2009;101:27-79.
19. Kulkarni S, Martin MP, Carrington M. The yin and yang of HLA and KIR in human disease. Semin Immunol. 2008;20:343-52.
20. Carrington M, et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med. 2005;201: 1069-75.
21. Naumova E, et al. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother. 2005;54:172-8.
22. Zhang Y. Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: Possible association with susceptibility to the disease. Leukemia res. 2010;34:55-8.
23. Besson C, et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS One. 2007;2:e406.
24. Butsch Kovacic M, et al. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev. 2005;14:2673-7.
25. Bahler DW, Hartung L, Hill S, Bowen GM, Vonderheid EC. CD158 k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry. Cytometry B Clin Cytom. 2008;74:156-62.
26. Morice WG, Kurtin PJ, Leibson PJ, Tefferi A, Hanson CA. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol. 2003;120:1026-36.
27. Nowakowski GS, Morice WG, Phyliky RL, Li CY, Tefferi A. Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol. 2005;128:490-2.
28. Lopez-Vazquez A, et al. Protective effect of the HLA-Bw4I80 epitope and the Killer Cell Immunoglobulin-Like Receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis. 2005; 192:162-5.
29. Al Omar S. Associations between genes for killer immunoglobulin- like receptors and their ligands in patients with solid tumors. Hum Immunol. 2010;71:976-81.